78 CBD 2:1 (Cherry Lemon Pheno)

78 CBD 2:1 (Cherry Lemon Pheno) is a cannabidiol-forward cannabis variety distinguished by its 2:1 CBD-to-THC ratio, selected specifically for the expressive phenotype that carries its characteristic cherry and lemon aromatic profile. The name itself tells much of the story — this is a purpose-driven selection, identified and stabilized for its unique sensory and chemical expression rather than potency chasing. The aroma and flavor profile of this phenotype are its most immediately recognizable qualities. As the name suggests, users commonly encounter a blend of ripe, sweet cherry notes layered over a bright, citrusy lemon character. These qualities suggest a terpene profile leaning toward fruity and tangy expression, though specific terpene percentages are not formally documented here. The flavor tends to carry through on the palate in a way consistent with the nose — sweet up front with a clean citrus finish that makes it approachable and pleasant for those who prefer fruitier expressions. With its 2:1 CBD-to-THC ratio, 78 CBD 2:1 (Cherry Lemon Pheno) sits in a category commonly sought by users interested in a more balanced cannabinoid experience. The elevated CBD presence relative to THC means commonly reported effects tend to lean toward a clear-headed, grounded sensation without the heavier psychoactive intensity associated with high-THC varieties. Users often describe a sense of calm and ease, with the modest THC content contributing a mild, functional lift rather than a pronounced euphoric effect. From a cultivation standpoint, specific grow data — such as flowering time, yield figures, or preferred growing environment — is not available for this particular selection. What can reasonably be inferred is that phenotype-specific selections like the Cherry Lemon expression require careful observation across multiple growing cycles to reliably reproduce the aromatic traits that define it. Growers working with CBD-dominant genetics generally find these varieties behave comparably to their THC-dominant counterparts in terms of basic cultivation requirements, though stability in cannabinoid ratios may warrant regular testing across harvests to confirm consistency. No documented offspring or notable breeding children are on record for this variety at this time. As a named phenotype within the broader 78 CBD 2:1 line, its significance lies primarily in demonstrating what selective pressure toward aroma and cannabinoid balance can produce — a reliable, characterful option within the growing space of CBD-forward cannabis.